Technology Stocks & Market Talk With Don Wolanchuk Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Technology Stocks & Market Talk With Don Wolanchuk

SOXL 44.18

-0.1%

Dec 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: w0z who wrote (150344)	12/7/2020 2:15:49 PM
From: w0z	Read Replies (1) of 207499

I wrote: "I am strongly considering adding Ivermectin (see page 3 in link below) which has recently been added based on good results in many clinical studies". bit.ly The video on the left side below gives an extremely high endorsement of Ivermectin for front line workers and high risk categories. covid19criticalcare.com The Front Line Covid-19 Critical Care Alliance has now developed a prophylactic and early outpatient combination treatment protocol for COVID-19 called I-Mask+. This protocol is centered around the use of Ivermectin, a well-known anti-parasite drug with recently discovered anti-viral and anti-inflammatory properties and a rapidly growing published medical evidence base demonstrating its unique and highly potent ability to inhibit SARS-CoV-2 replication. "We have 100,000 people in hospitals and I can guarantee you this would be much less if we used Ivermectin".

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next